The global unit dose packaging market is projected to grow from USD 29.1 Billion in 2024 to USD 43.8 Billion by 2029, at a CAGR of 8.5% during the forecast period. The major driving factors for the growth of the unit dose packaging market are the thriving pharmaceutical sector and surge in healthcare expenditure, rising demand for blister packaging, and consumer preference for convenience and portability driving demand for unit dose packaging. As the pharmaceutical industry grows, the demand for precise, efficient, and safe medication delivery systems rises. Unit dose packaging meets these needs by offering accurate, pre-measured doses, which reduce the risk of dosing errors and enhance patient safety. For example, pre-filled syringes and single-use vials ensure patients receive the exact amount of medication required, minimizing waste and improving treatment outcomes. The rising demand for blister packaging is significantly driving the growth of the unit dose packaging market due to its many advantages in ensuring medication safety, accuracy, and convenience. Blister packaging, which seals individual doses of medication in plastic and foil compartments, is widely favored in the pharmaceutical industry for protecting drugs from moisture and light, thereby maintaining their potency. Medications such as birth control pills and over-the-counter pain relievers are often packaged in blister packs, allowing patients to easily track their doses and adhere to their medication schedules.
Unit dose packaging involves packaging individual doses of a product in single-use containers, ensuring precise and convenient administration. In the pharmaceutical industry, it is essential for accurate medication dispensing, reducing errors, and enhancing patient compliance, particularly for complex regimens involving oral liquids, injectables, and specialized drugs. In the cosmetic and personal care sector, unit dose packaging provides hygienic, single-use solutions for products like serums, creams, and masks, maintaining product integrity and offering user convenience. The nutraceutical industry uses unit dose packaging for precise doses of supplements, vitamins, and health shots, improving compliance and ensuring freshness. Advances in biodegradable materials and smart packaging technologies are enhancing unit dose packaging, making it more sustainable and user-friendly across these industries.
To know about the assumptions considered for the study download the pdf brochure
The unit dose packaging market is fragmented in nature with key players being Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klöckner Pentaplast (UK), among others.
Pfizer Inc. is a global biopharmaceutical company that leverages scientific innovation and global resources to discover, develop, manufacture, and distribute biopharmaceutical products. The company operates through two segments: Biopharma and Business Innovation. The Biopharma segment focuses on three main customer segments: primary care, specialty care, and oncology. Pfizer's diversified portfolio includes medications for cardiovascular diseases, immunological disorders, oncology therapies, and vaccines. While primarily serving wholesalers, Pfizer also collaborates directly with retailers, hospitals, clinics, government organizations, and pharmacies. The company offers comprehensive R&D services and solutions for detecting specific ailments. With a global network of over 35 manufacturing locations and partnerships with more than 300 external suppliers, Pfizer ensures its medications reach over 180 countries.
Amcor Plc is a global leader in packaging solutions, recognized for its innovative and sustainable packaging products. The company serves various markets, including food & beverage, healthcare, home care, personal care, and technical applications. Amcor's primary goal is to produce packaging that is increasingly lighter, recyclable, and reusable, incorporating a growing percentage of recycled materials. The company operates through two segments: Flexible Packaging and Rigid Packaging. The Flexible Packaging segment operates 166 plants across 37 countries, employing over 36,000 people, and produces flexible packaging for food, beverages, healthcare, pharmaceuticals, personal care, and more. The Rigid Packaging segment runs 52 plants in 11 countries, with more than 5,000 employees, producing closures and bottles for healthcare, food, beverages, and other sectors. Amcor supplies its products to regions including Asia Pacific, Europe, North America, South America, and Africa.
Corning Incorporated is a leader in materials science innovation, renowned for its advancements in glass, ceramics, and optical physics. The company provides comprehensive solutions across various sectors, including optical communications, automotive, life sciences, pharmaceuticals, and environmental technologies. Its product range includes damage-resistant cover glass for mobile devices, precision glass for enhanced displays, optical fiber for communication networks, drug discovery and delivery acceleration tools, and clean-air technology for vehicles. Corning operates through five segments: Optical Communications, Display Technologies, Specialty Materials, Environmental Technologies, and Life Sciences. Any other businesses that do not meet the criteria for separate reporting are classified as Hemlock and Emerging Growth firms. The Optical Communications segment offers optical fiber, cable, and connectivity solutions. The Display Technologies segment focuses on glass substrates for LCD and OLED displays. The Specialty Materials segment provides Corning Gorilla Glass for mobile devices, semiconductor optics, ultra-flat glass wafers, and radiation shielding products. The Environmental Technologies segment delivers substrates and filters for vehicle emissions control. The Life Sciences segment supplies consumables, plastic vessels, cell culture media, and equipment. Corning manufactures its products at 125 plants across 15 countries worldwide.
The companies have initiated the following developments:
In July 2023, Pfizer Inc. launched a new single-dose flexible container for Ciprofloxacin in 5% Dextrose Injection, USP 200 mg/100 mL (2 mg/mL).
Related Reports:
Unit Dose Packaging Market by Form (Liquid, Solid, Powder, Gel), Material Type (Plastic, Glass, Paper, Aluminium), Product Type, End-use industry (Pharmaceuticals, Cosmetic & Personal Care, Nutraceuticals), and Region - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE